Investigating the effects of red wine-derived silver nanoparticles on neuroinflammation and microglial glucose uptake
Year: 2025
Type: article
Abstract: Microglial cells, the specialized immune cells within the central nervous system (CNS), play a crucial role in maintaining brain homeostasis and orchestrating immune responses. Their ability to switch between pro-inflammatory (M1) and anti-inflammatory (M2) states highlights their versatility in responding to CNS challenges. Microglia's dynamic nature allows them to adapt their metabolic activity based on their activation state, with inflammatory conditions often inducing a shift from mitochondrial oxidative phosphorylation to anaerobic glycolysis. This metabolic reprogramming supports the production of inflammatory mediators and leads to increased glucose consumption, which is crucial for neuronal function. Given that uncontrolled microglial activation is implicated in various neurodegenerative diseases, there is a growing interest in the relationship between microglial energy metabolism and neuroinflammation. Silver nanoparticles (AgNPs) have gained attention for their antimicrobial and anti-inflammatory properties, while epidemiological data shows polyphenols (e.g., resveratrol) present in wine have neuroprotective effects due to anti-inflammatory properties. This study investigated the potential of AgNPs synthesized through green (red wine-based, RW-AgNPs) and chemical (citrate-based, CS-AgNPs) methods in modulating microglial activation, inflammatory responses, and glucose metabolism under lipopolysaccharide-induced inflammation. The synthesized AgNPs were characterized using UV-Visible spectroscopy (UV-Vis), dynamic light scattering (DLS), high- resolution transmission electron microscopy (HRTEM), energy-dispersive X-ray spectroscopy (EDS), and Fourier-transform infrared (FTIR) spectroscopy. The RW-AgNPs demonstrated superior stability, comparable small size (14.31±3.54 nm versus 10.11±2.19 nm) and enhanced biocompatibility compared to CS-AgNPs. Functional assays revealed that both nanoparticle formulations mitigated LPS-induced cytotoxicity in C8B4 microglial cells, with RW-AgNPs exhibiting greater anti-inflammatory effects by significantly reducing TNF-α levels (measured using ELISA) and slightly enhancing IL-4 production. At 12.5 μg/mL, RW-AgNPs reduced TNF- α levels by 85.5%, while CS-AgNPs achieved only a 60.8% reduction. In addition to their immunomodulatory properties, both concentrations of RW-AgNPs and CS-AgNPs significantly decreased LPS-induced glucose uptake measured using a glucometer (p < 0.0001 compared to the LPS-treated group) with RW-AgNPs at 12.5 µg/mL exhibiting the lowest glucose uptake of 75.33 mmol/L. These findings highlighted the potential of green-synthesized AgNPs as a sustainable and effective strategy for managing neuroinflammation.
Author: Moeketsi, Dorothy Sellwane
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7220783161
